Literature DB >> 8750820

Low molecular weight heparin for anticoagulation during haemodialysis in children--a preliminary study.

I Van Biljon, R Van Damme-Lombaerts, A Demol, C Van Geet, W Proesmans, J Arnout.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8750820     DOI: 10.1007/bf02115637

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

1.  Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?

Authors:  C Van Geet; R Van Damme-Lombaerts; M Vanrusselt; A de Mol; W Proesmans; J Vermylen
Journal:  Thromb Haemost       Date:  1990-08-13       Impact factor: 5.249

2.  Low molecular weight heparin in hemodialysis and hemofiltration patients.

Authors:  J Schrader; R Valentin; H J Tönnis; U Hildebrand; W Stibbe; V W Armstrong; M Kandt; H Köstering; E Quellhorst
Journal:  Kidney Int       Date:  1985-11       Impact factor: 10.612

Review 3.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  3 in total
  2 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations.

Authors:  M T Nurmohamed; H ten Cate; J W ten Cate
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.